Comparison of prostate specific antigen, prostate specific membrane antigen, and LNCaP-based enzyme-linked immunosorbent assays in prostatic cancer patients and patients with benign prostatic enlargement

The Prostate ◽  
1995 ◽  
Vol 26 (3) ◽  
pp. 164-168 ◽  
Author(s):  
Gerald. P. Murphy ◽  
E. H. Holmes ◽  
A. L. Boynton ◽  
G. M. Kenny ◽  
S. J. Erickson ◽  
...  
Keyword(s):  
Cancer Patients ◽  
Prostate Specific Antigen ◽  
Prostatic Cancer ◽  
Specific Antigen ◽  
Prostate Specific Membrane Antigen ◽  
Benign Prostatic Enlargement ◽  
Prostatic Enlargement ◽  
Immunosorbent Assays ◽  
Specific Membrane

Can 68Ga-PSMA PET/CT-derived prostate-specific membrane antigen expression parameters predict prostate-specific antigen response to enzalutamide treatment?

2021 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Savaş Karyağar ◽  
Osman Güven ◽  
Sevda Sağlampinar Karyağar ◽  
Serdar Arici ◽  
Oğuzhan Selvi ◽  
...  
Keyword(s):  
Prostate Specific Antigen ◽  
Specific Antigen ◽  
Antigen Expression ◽  
Prostate Specific Membrane Antigen ◽  
Psma Pet ◽  
Pet Ct ◽  
Specific Membrane

Diagnostic Accuracy of Percent Free Prostate-Specific Antigen in Prostatic Pathology and Its Usefulness in Monitoring Prostatic Cancer Patients

2001 ◽  
Vol 67 (4) ◽  
pp. 272-282 ◽  
Author(s):  
Daniele Minardi ◽  
Andrea Benedetto Galosi ◽  
Alberto Recchioni ◽  
Lisy Giammarco ◽  
Mario Polito ◽  
...  
Keyword(s):  
Diagnostic Accuracy ◽  
Cancer Patients ◽  
Prostate Specific Antigen ◽  
Prostatic Cancer ◽  
Specific Antigen
Sign in / Sign up

Export Citation Format

Share Document